Milligan Sandra

Milligan Sandra is listed in filings as Director at Gossamer Bio, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Gossamer Bio, Inc. (GOSS) and Spyre Therapeutics, Inc. (SYRE). The current snapshot covers public activity from Jun 2, 2025 to Jun 5, 2026. Reported amounts are shown as $20.5K to $50.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.